Urologists v. Rad Oncs: New test shifts how doctors plan prostate cancer treatment

There are myriad prostate cancer screeners on the market, but a San Diego company’s test has an interesting spin: Researchers have found that the results of GenomeDx’s Decipher diagnostic shifts the way physicians recommend treatment for the disease, as seen in a recent Red Journal paper. The company’s genomic test, which it’s commercializing now, predicts the probability […]